IMCC (IM Cannabis) Cyclically Adjusted PS Ratio: (As of Aug. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IMCC IM Cannabis Corp IMCC
34 GF Score
Price $0.10
GF Value $1.30
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is IM Cannabis Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


IM Cannabis  (NAS:IMCC) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


IM Cannabis Cyclically Adjusted PS Ratio Related Terms


IM Cannabis Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for IM Cannabis's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IM Cannabis Cyclically Adjusted PS Ratio Chart

IM Cannabis Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.08 0.18 0.07 0.09 0.06

IM Cannabis Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.08 0.06 0.02 0.00

IMCC vs CBDY, CPMD, PLSH: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, IM Cannabis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IM Cannabis Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IM Cannabis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where IM Cannabis's Cyclically Adjusted PS Ratio falls into.


IMCC
34GF Score
IM Cannabis Corp IMCC
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IM Cannabis Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

IM Cannabis's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, IM Cannabis's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.584/333.9520*333.9520
=0.584

Current CPI (Jun. 2026) = 333.9520.

IM Cannabis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201604 0.000 239.261 0.000
201607 0.000 240.628 0.000
201610 0.000 241.729 0.000
201701 0.000 242.839 0.000
201704 0.000 244.524 0.000
201707 0.000 244.786 0.000
201710 0.000 246.663 0.000
201801 0.000 247.867 0.000
201804 0.000 250.546 0.000
201807 0.000 252.006 0.000
201901 0.000 251.712 0.000
201904 0.000 255.548 0.000
201907 0.000 256.571 0.000
201912 0.000 256.974 0.000
202003 1.582 258.115 2.047
202006 4.435 257.797 5.745
202009 9.260 260.280 11.881
202012 5.769 260.474 7.396
202103 10.212 264.877 12.875
202106 10.723 271.696 13.180
202109 5.323 274.310 6.480
202112 6.811 278.802 8.158
202203 8.837 287.504 10.265
202206 8.538 296.311 9.623
202209 8.546 296.808 9.615
202212 8.435 296.797 9.491
202303 4.277 301.836 4.732
202306 4.484 305.109 4.908
202309 4.096 307.789 4.444
202312 3.582 306.746 3.900
202403 3.730 312.332 3.988
202406 4.822 314.175 5.126
202409 4.592 315.301 4.864
202412 3.477 315.605 3.679
202503 2.822 319.799 2.947
202506 2.849 322.561 2.950
202509 2.058 324.800 2.116
202512 1.984 324.054 2.045
202603 1.067 330.213 1.079
202606 0.584 333.952 0.584

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is IM Cannabis (IMCC) Overvalued in 2026?

Based on GuruFocus' analysis, IM Cannabis stock appears to be undervalued. The current stock price of $0.10 is trading 91.9% below its estimated GF Value™ of $1.30. GuruFocus considers IM Cannabis to be Possible Value Trap.

Key valuation signals for IMCC:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $1.30 vs. price of $0.10 (91.9% below fair value)
  • GF Score™: 34/100 with 8 warning signs

No single metric tells the full story. See the IMCC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IM Cannabis Business Description

Address Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
34GF Score

Get the complete analysis for IMCC

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price
$1.30
GF Value